» Articles » PMID: 18606078

Recent Advances in Immunotherapy of Allergic Rhinitis

Overview
Date 2008 Jul 9
PMID 18606078
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Strategies of mucosal immunotherapy for allergic diseases.

Ye Y, Chuang Y, Chiang B Cell Mol Immunol. 2011; 8(6):453-61.

PMID: 21666705 PMC: 4012928. DOI: 10.1038/cmi.2011.17.

References
1.
Larche M . Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches. Pharmacol Ther. 2005; 108(3):353-61. DOI: 10.1016/j.pharmthera.2005.05.004. View

2.
Leatherman B, Owen S, Parker M, Chadwick S, Fornadley J, Colson D . Sublingual Immunotherapy: Past, present, paradigm for the future? A review of the literature. Otolaryngol Head Neck Surg. 2007; 136(3 Suppl):S1-20. DOI: 10.1016/j.otohns.2006.11.057. View

3.
Hayashi T, Mo J, Gong X, Rossetto C, Jang A, Beck L . 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci U S A. 2007; 104(47):18619-24. PMC: 2141826. DOI: 10.1073/pnas.0709261104. View

4.
Datta S, Cho H, Takabayashi K, Horner A, Raz E . Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications. Immunol Rev. 2004; 199:217-26. DOI: 10.1111/j.0105-2896.2004.00149.x. View

5.
Prussin C, Griffith D, Boesel K, Lin H, Foster B, Casale T . Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol. 2003; 112(6):1147-54. DOI: 10.1016/j.jaci.2003.10.003. View